4//SEC Filing
Rajangam Kanya 4
Accession 0001854270-25-000015
CIK 0001854270other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 7:02 PM ET
Size
8.3 KB
Accession
0001854270-25-000015
Insider Transaction Report
Form 4
Rajangam Kanya
Pres. & Chief Med. & Dev. Off.
Transactions
- Award
Stock Option (Right to Buy)
2025-03-06+235,088→ 235,088 totalExercise: $3.97Exp: 2034-12-19→ Common Stock (235,088 underlying) - Award
Common Stock
2025-03-07+78,363→ 86,984 total
Footnotes (3)
- [F1]The shares reported in this transaction represent restricted stock units ("RSUs") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan, as amended and restated (the "Amended and Restated Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from March 7, 2025, subject to the reporting person's continued service through the applicable vesting date.
- [F2]The option grant was approved by the Issuer's board of directors on December 20, 2024, subject to shareholder approval of the Amended and Restated Plan, under which the option was granted. The Issuer's shareholders approved the Amended and Restated Plan on March 6, 2025.
- [F3]Three-forty-eighth of the shares underlying this option vest on March 31, 2025 ("Vesting Commencement Date") and thereafter one-forty-eighth of the shares underlying this option vest in equal monthly installments from the Vesting Commencement Date, such that the option will be fully vested on the date forty-five months after the Vesting Commencement Date, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Senti Biosciences, Inc.
CIK 0001854270
Entity typeother
Related Parties
1- filerCIK 0001816676
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 7:02 PM ET
- Size
- 8.3 KB